Oyster Point Pharma Statistics Share Statistics Oyster Point Pharma has 0
shares outstanding. The number of shares has increased by 2.66%
in one year.
Shares Outstanding n/a Shares Change (YoY) 2.66% Shares Change (QoQ) 1.93% Owned by Institutions (%) n/a Shares Floating 8.83M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 170.04K, so 0% of the outstanding
shares have been sold short.
Short Interest 170.04K Short % of Shares Out n/a Short % of Float 1.35% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.55 and the forward
PE ratio is null.
Oyster Point Pharma's PEG ratio is
-0.12.
PE Ratio -4.55 Forward PE n/a PS Ratio 19.38 Forward PS n/a PB Ratio 4.78 P/FCF Ratio -5.23 PEG Ratio -0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Oyster Point Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.47,
with a Debt / Equity ratio of 0.93.
Current Ratio 7.47 Quick Ratio 7.26 Debt / Equity 0.93 Debt / EBITDA -0.96 Debt / FCF -1.02 Interest Coverage -25.96
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $80.99K Profits Per Employee $-344.53K Employee Count 303 Asset Turnover 0.11 Inventory Turnover 0.25
Taxes Income Tax 3.73M Effective Tax Rate -3.71%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Oyster Point Pharma's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.42 200-Day Moving Average 7.48 Relative Strength Index (RSI) 65.49 Average Volume (20 Days) 417,562
Income Statement In the last 12 months, Oyster Point Pharma had revenue of 24.54M
and earned -104.39M
in profits. Earnings per share was -4.01.
Revenue 24.54M Gross Profit 23.01M Operating Income -96.92M Net Income -104.39M EBITDA -96.78M EBIT -96.92M Earnings Per Share (EPS) -4.01
Full Income Statement Balance Sheet The company has 193.37M in cash and 92.73M in
debt, giving a net cash position of 100.64M.
Cash & Cash Equivalents 193.37M Total Debt 92.73M Net Cash 100.64M Retained Earnings -255.41M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -89.37M
and capital expenditures -1.49M, giving a free cash flow of -90.86M.
Operating Cash Flow -89.37M Capital Expenditures -1.49M Free Cash Flow -90.86M FCF Per Share -3.49
Full Cash Flow Statement Margins Gross margin is 93.79%, with operating and profit margins of -394.98% and -425.42%.
Gross Margin 93.79% Operating Margin -394.98% Pretax Margin -410.2% Profit Margin -425.42% EBITDA Margin -394.41% EBIT Margin -394.98% FCF Margin -370.25%
